Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
Regadenoson is a selective adenosine 2a (A2a) receptor agonist that is used in cardiac stress testing to evaluate for ischemic heart disease and has largely replaced adenosine in the modern era. Since adenosine receptors are involved in synaptic transmission between neurons throughout the central ne...
Saved in:
| Main Authors: | Sohab S. Radwan, Owen G. Schwartz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2019/6240605 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduced response to regadenoson with increased weight: An artificial intelligence–based quantitative myocardial perfusion study
by: Emmanouil Androulakis, et al.
Published: (2024-01-01) -
Transient ischemic dilation ratio in regadenoson, single isotope gated single-photon emission computed tomography myocardial perfusion imaging
by: Manolo Rubio, et al.
Published: (2017-07-01) -
Feasibility and safety of regadenoson stress perfusion protocol in pediatric transplant patients under general anesthesia
by: Nikkan Das, et al.
Published: (2025-01-01) -
Raising Awareness of ST-Segment Elevation Myocardial Infarction Triggered by Intravenous Regadenoson for Cardiac Stress Testing
by: Ruihai Zhou, MSc, MD
Published: (2025-07-01) -
Hemiplegic Migraine in a Patient With Neurologic Symptoms After Regadenoson Administration
by: Benjamin M. Moy, et al.
Published: (2025-07-01)